genetics – Page 3 – HCV Guidance

Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection

May 3, 2017
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

May 3, 2017
Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients

May 3, 2017
Late disappearance of hepatitis C virus RNA from peripheral blood mononuclear cells in patients with chronic hepatitis C in sustained response after alpha-interferon therapy

May 3, 2017
Hepatitis C — identifying patients with progressive liver injury

May 3, 2017
ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV

May 3, 2017
Treatment of patients with hepatitis C virus on the waiting list

May 3, 2017
Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy

May 3, 2017
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

May 3, 2017
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon

May 3, 2017